Global Diagnostic Testing of STDs Market: Governments Spruce up National STD Screening Initiatives, reports TMR

Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, and bioMerieux have been the leaders in the global diagnostic testing of STDs market so far. According to Transparency Market Research, a lot of the more prominent players in this market have established themselves in North America and Europe, the leading regions in the market. 

The global market for diagnostic testing of STDs is expected to advance at a CAGR of 9.2% from 2013 to 2019, in terms of revenue. This revenue is expected to reach US$140,029 mn by the end of 2019. The key market segment based on the STD type is chlamydia diagnostic testing. This segment is expected to reach US$41,910 mn by the end of 2019. Meanwhile, the segment of human papilloma virus (HPV) is expected to expand at a staggering CAGR of 73.4% from 2013 to 2019.

Europe to Ramp up Screening Diagnostic Testing of STDs

The diagnostic testing of STDs is highly interconnected between the key regions of the world and the type of STDs that are being screening. For instance, North America and Europe have a higher screening rate for Chlamydia, HPV, and syphilis, while developing economies focus more on ascertaining the prevalence of HIV and HPV. On a purely regional assessment of the global diagnostic testing of STDs market, North America has been at the lead so far. Europe and North America have had nearly equal shares in the market, but Europe is expected to overtake North America in the future owing to a faster CAGR. The key reasons for this include the lower cost of STD screening in Europe, and the ease of availability of laboratories or testing centers.

National Screening Programs to Help Combat Growing Number of STD Cases

“The number of patients testing positive for STDs has grown considerably over the past few decades and it is likely to continue increasing over the immediate future. This forms the primary factor boosting the demand for diagnostic testing of STDs across the world. An estimated 500 mn cases of STD are being discovered each year on a global scale and this is putting a massive pressure on the global healthcare industry. The fact that a lot of STDs remain asymptomatic during the initial infectious stage adds to the complications of standard screening procedures. As a result, many countries have begun implementing multiple initiatives that help screen and ascertain the national population that is actually positive for STDs,” states a TMR analyst.

Social Stigma Still Remains a Giant Hurdle for Diagnostic Testing of STDs

The social stigma associated with being diagnosed positive for STDs is mentally unbearable for almost all humans. As a result, they try to avoid STD screening tests, which forms the leading cause hindering the growth of the global diagnostic testing of STDs market. There are several studies that point to the declining number of visitors to specialized STD clinics.

Additionally, the global diagnostic testing of STDs market also faces a massive restraint of outreach. It has been found through studies that a large percentage of the global population that is STD positive resides in inaccessible areas, where medical treatment and screening procedures are hard to be implemented on a large scale.

“The providers of diagnostic testing of STDs need to band up with governments to implement secure and accurate screenings for citizens. This not only allows a larger population to enter the screening procedures, but also lets the players implement advanced technologies and thus obtain a greater profit,” adds the analyst.

The information presented in this review is based on a Transparency Market Research report, titled, “Diagnostic Testing of STDs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”

Key segments of the Global Diagnostic Testing of STDs Market

Segmentation based on STD type

  • Herpes Simplex Virus (HSV) testing
  • Chancroid testing
  • Human Papilloma Virus (HPV) testing
  • P&S Syphilis testing
  • Human Immunodeficiency Virus (HIV) testing
  • Gonorrhea testing
  • Chlamydia testing

Segmentation based on location

  • Point-of-Care (POC) Testing
  • Laboratory Testing

Major geographies analyzed under this research report are: 

  • Europe
  • North America 
  • Asia-Pacific 
  • Rest of the World 

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

7 of 10 large enterprizes view our Report to take the right decision.

View Report